argenx SE
SWB:1AEA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
argenx SE
SWB:1AEA
|
NL |
|
R
|
Ryman Healthcare Ltd
OTC:RHCGF
|
NZ |
|
Vicat SA
OTC:SDCVF
|
FR |
|
Viscofan SA
OTC:VSCFF
|
ES |
|
P
|
Pulsar Helium Inc
XTSX:PLSR
|
CA |
|
B
|
Brown & Brown Inc
XMUN:BTW
|
US |
Wall St Price Targets
1AEA Price Targets Summary
argenx SE
According to Wall Street analysts, the average 1-year price target for 1AEA is 891.15 EUR with a low forecast of 730.12 EUR and a high forecast of 1 256.33 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1AEA's stock price target?
Price Target
891.15
EUR
According to Wall Street analysts, the average 1-year price target for 1AEA is 891.15 EUR with a low forecast of 730.12 EUR and a high forecast of 1 256.33 EUR.
What is the Revenue forecast for argenx SE?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Revenue has been 79%. The projected CAGR for the next 8 years is 16%.
What is the Operating Income forecast for argenx SE?
Projected CAGR
26%
The compound annual growth rate for Operating Income over the next 8 years is 26%.
What is the Net Income forecast for argenx SE?
Projected CAGR
21%
The compound annual growth rate for Net Income over the next 8 years is 21%.
